CVS - CVS Health Corporation

NYSE - NYSE Delayed Price. Currency in USD
+0.53 (+0.72%)
At close: 4:00PM EDT

75.00 +0.37 (0.50%)
Pre-Market: 8:26AM EDT

Stock chart is not supported by your current browser
Previous Close74.10
Bid74.20 x 1000
Ask75.10 x 7300
Day's Range74.20 - 75.20
52 Week Range69.30 - 88.58
Avg. Volume5,559,855
Market Cap75.87B
PE Ratio (TTM)14.87
EPS (TTM)5.02
Earnings DateNov 6, 2017 - Nov 10, 2017
Forward Dividend & Yield2.00 (2.46%)
Ex-Dividend Date2017-07-20
1y Target Est86.75
Trade prices are not sourced from all markets
  • Market Realist6 minutes ago

    Walgreens Could See Robust Earnings Growth in Fiscal 4Q17

    For the first nine months of fiscal 2017, Walgreens Boots Alliance’s adjusted diluted net earnings per share increased 7.7% YoY to $3.79.

  • Market Realist2 hours ago

    What’s Driving Economic Moats

    "How Moats Translate into Sustainable Competitive Advantages" is a five-part moat investing education series that explores the primary sources of economic moats.

  • Market Realist2 hours ago

    Walgreens’ Top Line ahead of Its Fiscal 4Q17 Results

    During the first nine months of 2017 (or 9M17), Walgreens Boots Alliance’s total sales increased 0.9% YoY to $89.5 billion.

  • MarketWatch2 hours ago

    Is Amazon getting into the pharmacy business? This is what you need to know

    The massive online retailer with a reputation for disruption could be coming for the notoriously complex, opaque drug industry.

  • ACCESSWIRE2 hours ago

    Dividend Coverage: This Pharmacy Company has a Dividend Yield of 2.75%; Will Trade Ex-Dividend on October 23, 2017

    LONDON, UK / ACCESSWIRE / October 20, 2017 / Pro-Trader Daily takes a closer look at CVS Health Corp. (NYSE: CVS ) as the Company's stock will begin trading ex-dividend on October 23, 2017. To capture ...

  • Market Realist15 hours ago

    Can Walgreens Exceed Analyst Expectations in Fiscal 4Q17?

    Walgreens Boots Alliance (WBA) is slated to release its fiscal 4Q17 earnings on October 25. WBA's total sales are expected to reach $29.6 billion, a 4.6% increase over its fiscal 4Q16 sales.

  • You Should Buy Rite Aid Corporation Stock Only If This Happens
    InvestorPlace19 hours ago

    You Should Buy Rite Aid Corporation Stock Only If This Happens

    Rite Aid Corporation (NYSE:RAD) investors certainly haven’t been faced with a shortage of things to chew on of late. The failure of Walgreen’s initial plan to outright acquire all shares of RAD stock in 2015 followed by the no-go on 2016’s revised plan to only buy 2,186 Rite Aid units — WBA is now only acquiring 1,932 of Rite Aid’s 4,560 stores — spurred mounds of investor concern, as a large cash infusion was seen as the only way to save the struggling Rite Aid Corporation. Here’s the thing: Rite Aid was in trouble, maybe even doomed, well before Walgreen’s was interested.

  • No Pharmacy Has the Cure to Amazon Stock Price — Yet
    InvestorPlace22 hours ago

    No Pharmacy Has the Cure to Amazon Stock Price — Yet

    After shocking the grocery world with the Whole Foods purchase just a couple months ago, Amazon appears set to make another big move. Reports last week suggest that Amazon will make a final decision as to whether it joins the pharmacy space or not by Thanksgiving. The analysts at Leerink, in fact, suggest that it’s now a matter of when Amazon starts competing in pharmacy, not if.

  • Forbesyesterday

    Why Drug Makers Should Worry About Anthem's New PBM

    Insurers are closing ranks around a model that brings the PBM closer to the health plan in hopes of creating a savvier buyer of prescription medicines while seeking more transparency.

  • MarketWatchyesterday

    Anthem dumps Express Scripts in favor of starting its own pharmacy-benefit manager

    Anthem’s entry is notable in a highly concentrated industry dominated by just a few large players.

  • Reutersyesterday

    PRESS DIGEST- New York Times business news - Oct 19

    The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - Kenneth I. Chenault, one of the longest-serving executives ...

  • The Wall Street Journalyesterday

    [$$] Anthem to Launch Its Own Pharmacy-Benefit Manager

    Anthem plans to launch its own pharmacy-benefit manager, serviced by CVS Health, in 2020 after the conclusion of its contract with Express Scripts.

  • TheStreet.com2 days ago

    Dow Closes Above 23,000 for First Time as Stocks Surge to New Records

    After all scoring intraday record highs, the Dow, S&P 500 and Nasdaq all set record closing prices Wednesday.

  • Anthem Jumps Into Prescription Business As Amazon Speculation Swirls
    Investor's Business Daily2 days ago

    Anthem Jumps Into Prescription Business As Amazon Speculation Swirls

    Anthem will launch its own pharmacy benefit management business, relying heavily on CVS Health for both back-end processing and retail distribution.

  • TheStreet.com2 days ago

    IBM Helps Lift Dow Past 23,000 as Stocks Advance Higher

    All three benchmark indexes snag intraday records on Wednesday.

  • Amazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot
    Bloomberg2 days ago

    Amazon, Anthem, Congress Put Drug Benefits Firms in Hot Spot

    Being the middleman standing between drugmakers and insurance companies is getting to be more uncomfortable.

  • Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal
    InvestorPlace2 days ago

    Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal

    Anthem Inc says that it will be creating IngenioRx to act as its new pharmacy benefits manager. This will take place in 2020, which is when the company’s current pharmacy benefits manager contract expires. Anthem Inc notes that it will be combining its IngenioRx with services from CVS Health Corp starting on Jan. 1, 2020.

  • Reuters2 days ago

    Health insurer Anthem takes pharmacy business in house, taps CVS to help

    Health insurer Anthem Inc will start managing its billions of dollars of patient prescriptions itself in 2020, it said on Wednesday, ending a deal with Express Scripts Holding Co that had deteriorated into lawsuits over terms. Anthem said it would save $4 billion annually in the new contract with drug retailer CVS Health Corp, which will handle prescription fulfillment and claims processing starting in 2020 for five years for the new company, called IngenioRX. The new structure gives Anthem more control to lower healthcare costs, expand contracting with doctors and hospitals based on health outcomes and work on lowering annual increases in medical costs, Anthem Chief Executive Joseph Swedish said in an interview.

  • Barrons.com2 days ago

    Come On, Express Scripts! Could It Have Really Gone Any Other Way?

    The contentious pricing battle between Anthem (ANTM) and Express Scripts (ESRX) has come to an end, and it isn’t with reconciliation. Early today, Anthem, one of the nation’s largest providers of Blue Cross health plans, announced it would launch its own pharmacy benefit manager, IngenioRx, in 2020 to provide services to Anthem health plans, as well as outside customers. In a separate announcement, Anthem said it has inked a five-year deal with CVS Health (CVS) to process claims for IngenioRx and fill prescriptions.

  • In the Saga of Rite Aid Corporation, Amazon Plays Godot
    InvestorPlace2 days ago

    In the Saga of Rite Aid Corporation, Amazon Plays Godot

    Amazon is the off-stage character dominating the on-stage discussion. Its ambition to enter the pharmacy business is well-known. But will it? Rite Aid, with 2,336 stores following the sale of its other operations to Walgreens Boots Alliance Inc. (NYSE:WBA), which would have acquired the whole company but for the Federal Trade Commission’s objections, would seem to be a natural vehicle for such an entrance.

  • Anthem will turn to CVS after troubled Express Scripts deal
    Associated Press2 days ago

    Anthem will turn to CVS after troubled Express Scripts deal

    Anthem has found a new partner to help run prescription drug coverage after the Blue Cross-Blue Shield insurer's rocky relationship with Express Scripts ends. The nation's second-largest insurer says it ...

  • Forbes2 days ago

    Anthem Partners With CVS Health To Launch New PBM

    Anthem will launch its own new pharmacy benefit management company called IngenioRx in partnership with CVS Health, effective in January of 2020.

  • TheStreet.com2 days ago

    Anthem Inks Deal With CVS for New Pharmacy Benefits Manager

    CVS will take over services for Anthem's pharmacy benefits manager IngenioRx when Anthem's deal with Express Scripts runs out in 2020.

  • 4 health stocks and a gamer in the Blitz
    CNBC Videos2 days ago

    4 health stocks and a gamer in the Blitz

    Big movers in today's blitz